BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Witchel SF, Oberfield SE, Peña AS. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls. J Endocr Soc 2019;3:1545-73. [PMID: 31384717 DOI: 10.1210/js.2019-00078] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 17.3] [Reference Citation Analysis]
Number Citing Articles
1 Yen H, Chang YT, Yee FJ, Huang YC. Metformin Therapy for Acne in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. Am J Clin Dermatol 2021;22:11-23. [PMID: 33048332 DOI: 10.1007/s40257-020-00565-5] [Reference Citation Analysis]
2 Corrie L, Gulati M, Singh SK, Kapoor B, Khursheed R, Awasthi A, Vishwas S, Chellappan DK, Gupta G, Jha NK, Anand K, Dua K. Recent updates on animal models for understanding the etiopathogenesis of polycystic ovarian syndrome. Life Sci 2021;280:119753. [PMID: 34171379 DOI: 10.1016/j.lfs.2021.119753] [Reference Citation Analysis]
3 Ibáñez L, Díaz M, García-Beltrán C, Malpique R, Garde E, López-Bermejo A, de Zegher F. Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome. J Endocr Soc 2020;4:bvaa032. [PMID: 32342022 DOI: 10.1210/jendso/bvaa032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhao J, Li D, Tang H, Tang L. Association of vascular endothelial growth factor polymorphisms with polycystic ovarian syndrome risk: a meta-analysis. Reprod Biol Endocrinol 2020;18:18. [PMID: 32164758 DOI: 10.1186/s12958-020-00577-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Jiang X, Deng Q, Stener-Victorin E. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis. Hum Reprod 2021;36:2382-91. [PMID: 34051085 DOI: 10.1093/humrep/deab119] [Reference Citation Analysis]
6 Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int J Mol Sci 2022;23:583. [PMID: 35054768 DOI: 10.3390/ijms23020583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Aversa A, La Vignera S, Rago R, Gambineri A, Nappi RE, Calogero AE, Ferlin A. Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions. Front Endocrinol (Lausanne) 2020;11:516. [PMID: 32849300 DOI: 10.3389/fendo.2020.00516] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
8 Dietz de Loos A, Hund M, Buck K, Meun C, Sillman J, Laven JSE. Antimüllerian hormone to determine polycystic ovarian morphology. Fertil Steril 2021;116:1149-57. [PMID: 34579824 DOI: 10.1016/j.fertnstert.2021.05.094] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Abdolahian S, Tehrani FR, Amiri M, Ghodsi D, Yarandi RB, Jafari M, Majd HA, Nahidi F. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Endocr Disord 2020;20:71. [PMID: 32429890 DOI: 10.1186/s12902-020-00552-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
10 Wu Z, Fang L, Li Y, Yan Y, Thakur A, Cheng JC, Sun YP. Association of circulating monocyte chemoattractant protein-1 levels with polycystic ovary syndrome: A meta-analysis. Am J Reprod Immunol 2021;86:e13407. [PMID: 33638245 DOI: 10.1111/aji.13407] [Reference Citation Analysis]
11 Mohammadi M, Fatemi I, Taghipour Z, Azin M, Kaeidi A, Hakimizadeh E, Taghizadeh R, Hassanipour M. Polycystic Ovary Syndrome Can Lead to Neurocognitive Changes in Female Rats Treated with Letrozole. Arch Neurosci 2021;8. [DOI: 10.5812/ans.112023] [Reference Citation Analysis]
12 Rehman K, Haider K, Akash MSH. Cigarette smoking and nicotine exposure contributes for aberrant insulin signaling and cardiometabolic disorders. Eur J Pharmacol 2021;909:174410. [PMID: 34375672 DOI: 10.1016/j.ejphar.2021.174410] [Reference Citation Analysis]
13 Zia A, Hakim S, Khan AU, Bey A, Ateeq H, Parveen S, Khalid S, Yusufi F. Bone markers and bone mineral density associates with periodontitis in females with poly-cystic ovarian syndrome. J Bone Miner Metab. [DOI: 10.1007/s00774-021-01302-6] [Reference Citation Analysis]
14 Tennilä J, Jääskeläinen J, Utriainen P, Voutilainen R, Häkkinen M, Auriola S, Morin-Papunen L, Liimatta J. PCOS Features and Steroid Profiles Among Young Adult Women with a History of Premature Adrenarche. J Clin Endocrinol Metab 2021:dgab385. [PMID: 34060603 DOI: 10.1210/clinem/dgab385] [Reference Citation Analysis]
15 Abdalla M, Deshmukh H, Atkin SL, Sathyapalan T. miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review. Life Sci 2020;259:118174. [PMID: 32745529 DOI: 10.1016/j.lfs.2020.118174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Dapas M, Lin FTJ, Nadkarni GN, Sisk R, Legro RS, Urbanek M, Hayes MG, Dunaif A. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis. PLoS Med 2020;17:e1003132. [PMID: 32574161 DOI: 10.1371/journal.pmed.1003132] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
17 Pastoor H, Both S, Timman R, Laan ETM, Laven JSE. Sexual Function in Women With Polycystic Ovary Syndrome: Design of an Observational Prospective Multicenter Case Control Study. Sex Med 2020;8:718-29. [PMID: 32798148 DOI: 10.1016/j.esxm.2020.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Alnafjan AA, Alkhuriji AF, Alobaid HM, Babay ZA, Khalil MI. Association of FTO gene variants rs9939609 and rs1421085 with polycystic ovary syndrome. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00263-3] [Reference Citation Analysis]
19 Lee EB, Chakravarthi VP, Wolfe MW, Rumi MAK. ERβ Regulation of Gonadotropin Responses during Folliculogenesis. Int J Mol Sci 2021;22:10348. [PMID: 34638689 DOI: 10.3390/ijms221910348] [Reference Citation Analysis]
20 Fitzgerald S, Stamoulis C, Gooding HC, DiVasta AD. Characteristics of Adolescents with Differing Polycystic Ovary Syndrome Phenotypes. J Pediatr Adolesc Gynecol 2020;33:697-702. [PMID: 32889085 DOI: 10.1016/j.jpag.2020.08.015] [Reference Citation Analysis]
21 Street ME, Cirillo F, Catellani C, Dauriz M, Lazzeroni P, Sartori C, Moghetti P. Current treatment for polycystic ovary syndrome: focus on adolescence. Minerva Pediatr 2020;72:288-311. [PMID: 32418411 DOI: 10.23736/S0026-4946.20.05861-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Tang ZR, Zhang R, Lian ZX, Deng SL, Yu K. Estrogen-Receptor Expression and Function in Female Reproductive Disease. Cells 2019;8:E1123. [PMID: 31546660 DOI: 10.3390/cells8101123] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 13.7] [Reference Citation Analysis]
23 Rushing JS, Santoro N. Fertility Issues in Polycystic Ovarian Disease: A Systematic Approach. Endocrinol Metab Clin North Am 2021;50:43-55. [PMID: 33518185 DOI: 10.1016/j.ecl.2020.10.004] [Reference Citation Analysis]
24 Kamalipour F, Jalali H, Azarnia M. Comparison the Effect of Metformin and Clomiphene Citrate on Sirtuin3 gene Expression in the Oocytes of Mice with Polycystic Ovary Syndrome. Iran J Pharm Res 2020;19:160-8. [PMID: 33841532 DOI: 10.22037/ijpr.2020.113321.14236] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Shpakov AO. Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms. Pharmaceuticals (Basel) 2021;14:42. [PMID: 33429918 DOI: 10.3390/ph14010042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Capozzi A, Scambia G, Lello S. Polycystic ovary syndrome (PCOS) and adolescence: How can we manage it? Eur J Obstet Gynecol Reprod Biol 2020;250:235-40. [PMID: 32497923 DOI: 10.1016/j.ejogrb.2020.04.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Doretto L, Mari FC, Chaves AC. Polycystic Ovary Syndrome and Psychotic Disorder. Front Psychiatry 2020;11:543. [PMID: 32587538 DOI: 10.3389/fpsyt.2020.00543] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Abbott DH, Rogers J, Dumesic DA, Levine JE. Naturally Occurring and Experimentally Induced Rhesus Macaque Models for Polycystic Ovary Syndrome: Translational Gateways to Clinical Application. Med Sci (Basel) 2019;7:E107. [PMID: 31783681 DOI: 10.3390/medsci7120107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
29 Nicolaides NC, Matheou A, Vlachou F, Neocleous V, Skordis N. Polycystic ovarian syndrome in adolescents: From diagnostic criteria to therapeutic management. Acta Biomed 2020;91:e2020085. [PMID: 32921781 DOI: 10.23750/abm.v91i3.10162] [Reference Citation Analysis]
30 Rodriguez Paris V, Edwards MC, Aflatounian A, Bertoldo MJ, Ledger WL, Handelsman DJ, Gilchrist RB, Walters KA. Pathogenesis of Reproductive and Metabolic PCOS Traits in a Mouse Model. J Endocr Soc 2021;5:bvab060. [PMID: 34056500 DOI: 10.1210/jendso/bvab060] [Reference Citation Analysis]
31 Kolhe JV, Chhipa AS, Butani S, Chavda V, Patel SS. PCOS and Depression: Common Links and Potential Targets. Reprod Sci 2021. [PMID: 34642910 DOI: 10.1007/s43032-021-00765-2] [Reference Citation Analysis]
32 Lenert ME, Chaparro MM, Burton MD. Homeostatic Regulation of Estrus Cycle of Young Female Mice on Western Diet. J Endocr Soc 2021;5:bvab010. [PMID: 33733019 DOI: 10.1210/jendso/bvab010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Shi Q, Liu R, Chen L. Ferroptosis inhibitor ferrostatin‑1 alleviates homocysteine‑induced ovarian granulosa cell injury by regulating TET activity and DNA methylation. Mol Med Rep 2022;25:130. [PMID: 35169856 DOI: 10.3892/mmr.2022.12645] [Reference Citation Analysis]
34 Kalra S, Bhattacharya S, Rawal P. Hepatocrinology. Med Sci (Basel) 2021;9:39. [PMID: 34205986 DOI: 10.3390/medsci9020039] [Reference Citation Analysis]
35 Abdelrahman A, Mahmoud AA, Lamie Fanous Y, Abd Elhaliem NG, Elalaf H. Impact of erythropoietin and myoinositol versus metformin on insulin resistance in a rat model of polycystic ovary syndrome. Arch Physiol Biochem 2021;:1-12. [PMID: 34297646 DOI: 10.1080/13813455.2021.1949023] [Reference Citation Analysis]
36 Berry K, Lim J, Zaenglein AL. Acne Vulgaris: Treatment Made Easy for the Primary Care Physician. Pediatr Ann 2020;49. [DOI: 10.3928/19382359-20200211-01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
37 Lenert ME, Burton MD. Acute effects of a high-fat diet on estrous cycling and body weight of intact female mice. Neuropsychopharmacology 2022;47:418-9. [PMID: 34453116 DOI: 10.1038/s41386-021-01164-6] [Reference Citation Analysis]
38 Abdalla MA, Deshmukh H, Atkin S, Sathyapalan T. A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2020;11:2042018820938305. [PMID: 32670541 DOI: 10.1177/2042018820938305] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
39 Elenis E, Desroziers E, Persson S, Sundström Poromaa I, Campbell RE. Early initiation of anti-androgen treatment is associated with increased probability of spontaneous conception leading to childbirth in women with polycystic ovary syndrome: a population-based multiregistry cohort study in Sweden. Hum Reprod 2021;36:1427-35. [PMID: 33454768 DOI: 10.1093/humrep/deaa357] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Yumiceba V, López-Cortés A, Pérez-Villa A, Yumiseba I, Guerrero S, García-Cárdenas JM, Armendáriz-Castillo I, Guevara-Ramírez P, Leone PE, Zambrano AK, Paz-Y-Miño C. Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis. Front Endocrinol (Lausanne) 2020;11:585130. [PMID: 33329391 DOI: 10.3389/fendo.2020.585130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Shojaei-Zarghani S, Rafraf M. Resveratrol and Markers of Polycystic Ovary Syndrome: a Systematic Review of Animal and Clinical Studies. Reprod Sci 2021. [PMID: 34312768 DOI: 10.1007/s43032-021-00653-9] [Reference Citation Analysis]
42 Song L, Yu J, Zhang D, Li X, Chen L, Cai Z, Yu C. Androgen Excess Induced Mitochondrial Abnormality in Ovarian Granulosa Cells in a Rat Model of Polycystic Ovary Syndrome. Front Endocrinol 2022;13:789008. [DOI: 10.3389/fendo.2022.789008] [Reference Citation Analysis]
43 Zhou G, Gu Y, Zhou F, Zhang H, Zhang M, Zhang G, Wu L, Hua K, Ding J. Adipocytes-Derived Extracellular Vesicle-miR-26b Promotes Apoptosis of Cumulus Cells and Induces Polycystic Ovary Syndrome. Front Endocrinol 2022;12:789939. [DOI: 10.3389/fendo.2021.789939] [Reference Citation Analysis]
44 Abdalla MA, Shah N, Deshmukh H, Sahebkar A, Östlundh L, Al-Rifai RH, Atkin SL, Sathyapalan T. Effect of pharmacological interventions on lipid profiles and C-reactive protein in polycystic ovary syndrome: A systematic review and meta-analysis. Clin Endocrinol (Oxf) 2021. [PMID: 34779013 DOI: 10.1111/cen.14636] [Reference Citation Analysis]
45 Rzońca E, Kosowski A, Bień A, Gotlib J, Wejnarski A, Jarzębowska M, Gałązkowski R, Rzońca P. Polycystic Ovary Syndrome and Endometriosis as Reasons for Women's Admission to Outpatient Specialist Care in Poland-A Retrospective Analysis. Int J Environ Res Public Health 2021;18:1442. [PMID: 33557058 DOI: 10.3390/ijerph18041442] [Reference Citation Analysis]
46 Bednarz K, Kowalczyk K, Cwynar M, Czapla D, Czarkowski W, Kmita D, Nowak A, Madej P. The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome. IJMS 2022;23:4334. [DOI: 10.3390/ijms23084334] [Reference Citation Analysis]
47 Shahbaz M, Raza N, Islam M, Imran M, Ahmad I, Meyyazhagan A, Pushparaj K, Balasubramanian B, Park S, Rengasamy KRR, Gondal TA, El-Ghorab A, Abdelgawad MA, Ghoneim MM, Wan C. The nutraceutical properties and health benefits of pseudocereals: a comprehensive treatise. Crit Rev Food Sci Nutr 2022;:1-13. [PMID: 35549783 DOI: 10.1080/10408398.2022.2071205] [Reference Citation Analysis]
48 Raj D, Pooja F, Chhabria P, Kalpana F, Lohana S, Lal K, Shahid W, Naz S, Shahid S, Khalid D. Frequency of Subclinical Hypothyroidism in Women With Polycystic Ovary Syndrome. Cureus 2021;13:e17722. [PMID: 34659936 DOI: 10.7759/cureus.17722] [Reference Citation Analysis]
49 Duică F, Dănilă CA, Boboc AE, Antoniadis P, Condrat CE, Onciul S, Suciu N, Creţoiu SM, Varlas VN, Creţoiu D. Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne) 2021;12:614679. [PMID: 33679617 DOI: 10.3389/fendo.2021.614679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Fulghesu AM, Piras C, Dessì A, Succu C, Atzori L, Pintus R, Gentile C, Angioni S, Fanos V. Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS). Metabolites 2021;11:437. [PMID: 34357331 DOI: 10.3390/metabo11070437] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Fu YX, Wang H, Hu T, Wang FM, Hu R. Factors affecting the accuracy and reliability of the measurement of anti-Müllerian hormone concentration in the clinic. J Int Med Res 2021;49:3000605211016161. [PMID: 34044635 DOI: 10.1177/03000605211016161] [Reference Citation Analysis]
52 Diao X, Yao L, Wang Y, Zhang X, Sun H, Lao K, Ma H. Identification of critical miRNAs and mRNAs associated with polycystic ovary syndrome. J Obstet Gynaecol Res 2021;47:1416-24. [PMID: 33590597 DOI: 10.1111/jog.14707] [Reference Citation Analysis]
53 Femi-Olabisi FJ, Ishola AA, Faokunla O, Agboola AO, Babalola BA. Evaluation of the inhibitory potentials of selected compounds from Costus spicatus (Jacq.) rhizome towards enzymes associated with insulin resistance in polycystic ovarian syndrome: an in silico study. J Genet Eng Biotechnol 2021;19:176. [PMID: 34812979 DOI: 10.1186/s43141-021-00276-2] [Reference Citation Analysis]
54 Fan L, Wang C, Zhan P, Liu Y. miR-141-3p is Poorly Expressed in Polycystic Ovary Syndrome and Correlates with Glucose and Lipid Metabolism. Int J Endocrinol 2021;2021:2022938. [PMID: 34659401 DOI: 10.1155/2021/2022938] [Reference Citation Analysis]
55 Asanidze E, Kristesashvili J, Parunashvili N, Karelishvili N, Etsadashvili N. Challenges in diagnosis of polycystic ovary syndrome in adolescence. Gynecol Endocrinol 2021;37:819-22. [PMID: 34184963 DOI: 10.1080/09513590.2021.1943344] [Reference Citation Analysis]
56 Manique MES, Ferreira AMAP. Polycystic Ovary Syndrome in Adolescence: Challenges in Diagnosis and Management. Rev Bras Ginecol Obstet 2022;44:425-33. [PMID: 35623621 DOI: 10.1055/s-0042-1742292] [Reference Citation Analysis]
57 Deniz R, Yavuzkir S, Ugur K, Ustebay DU, Baykus Y, Ustebay S, Aydin S. Subfatin and asprosin, two new metabolic players of polycystic ovary syndrome. J Obstet Gynaecol 2021;41:279-84. [PMID: 32608281 DOI: 10.1080/01443615.2020.1758926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
58 Le NSV, Le MT, Nguyen ND, Tran NQT, Nguyen QHV, Cao TN. A Cross-Sectional Study on Potential Ovarian Volume and Related Factors in Women with Polycystic Ovary Syndrome from Infertile Couples. Int J Womens Health 2021;13:793-801. [PMID: 34512036 DOI: 10.2147/IJWH.S329082] [Reference Citation Analysis]
59 Pereira-Eshraghi CF, Chiuzan C, Zhang Y, Tao RH, McCann M, Neugut YD, Printz A, Fennoy I, Cree-Green M, Oberfield SE, Sopher AB. Obesity and Insulin Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women. Horm Res Paediatr 2019;92:365-71. [PMID: 32348991 DOI: 10.1159/000507079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Stewart CE, Sohrabji F. Gonadal hormones and stroke risk: PCOS as a case study. Front Neuroendocrinol 2020;58:100853. [PMID: 32640267 DOI: 10.1016/j.yfrne.2020.100853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Fazel Torshizi F, Chamani M, Khodaei HR, Sadeghi AA, Hejazi SH, Heravi RM. The Effects of Zinc Methionine on Reproductive and Thyroid Hormones in Rats with Polycystic Ovarian Syndrome. Adv Biomed Res 2020;9:57. [PMID: 33457340 DOI: 10.4103/abr.abr_144_20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Conlon JL, Malcolm S, Monaghan M. Diagnosis and treatment of polycystic ovary syndrome in adolescents. JAAPA 2021;34:15-22. [PMID: 34524161 DOI: 10.1097/01.JAA.0000791468.37054.5d] [Reference Citation Analysis]
63 Lucà F, Abrignani MG, Parrini I, Di Fusco SA, Giubilato S, Rao CM, Piccioni L, Cipolletta L, Passaretti B, Giallauria F, Leone A, Francese GM, Riccio C, Gelsomino S, Colivicchi F, Gulizia MM. Update on Management of Cardiovascular Diseases in Women. J Clin Med 2022;11:1176. [PMID: 35268267 DOI: 10.3390/jcm11051176] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
64 Hou F, Li J, Peng J, Teng Z, Feng J, Xia W. LncRNA TMPO-AS1 suppresses the maturation of miR-335-5p to participate in polycystic ovary syndrome. J Ovarian Res 2021;14:99. [PMID: 34330309 DOI: 10.1186/s13048-021-00848-3] [Reference Citation Analysis]
65 Mawaddatina T, Budihastuti UR, Rahayu D. Waist circumference, hip circumference, arm span, and waist-to-hip ratio high risk of polycystic ovarian syndrome. Scott Med J 2021;66:186-90. [PMID: 34661497 DOI: 10.1177/00369330211043206] [Reference Citation Analysis]
66 Abuelezz NZ, E Shabana M, Rashed L, Nb Morcos G. Nanocurcumin Modulates miR-223-3p and NF-κB Levels in the Pancreas of Rat Model of Polycystic Ovary Syndrome to Attenuate Autophagy Flare, Insulin Resistance and Improve ß Cell Mass. J Exp Pharmacol 2021;13:873-88. [PMID: 34475786 DOI: 10.2147/JEP.S323962] [Reference Citation Analysis]
67 Bizoń A, Franik G, Niepsuj J, Czwojdzińska M, Leśniewski M, Nowak A, Szynkaruk-Matusiak M, Madej P, Piwowar A. The Associations between Sex Hormones and Lipid Profiles in Serum of Women with Different Phenotypes of Polycystic Ovary Syndrome. J Clin Med 2021;10:3941. [PMID: 34501389 DOI: 10.3390/jcm10173941] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Ramachandran S, Nikitha J, Gopi C, Amala M, Dhanaraju MD. Effect of Prunus dulcis and Salvia hispenica in the management of polycystic ovary syndrome in Wistar rats. J Taibah Univ Med Sci 2020;15:122-8. [PMID: 32368208 DOI: 10.1016/j.jtumed.2020.02.002] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]